WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem...

Related Keywords

Germany ,Japan ,Shanghai ,China ,United States ,Wuxi ,Jiangsu ,Singapore ,Ireland ,Kyoto ,Toregem Biopharma ,Honoka Kiso ,Chris Chen ,Inflamm Regen ,Katsu Takahashi ,Contract Research ,Toregem Bio Pharma Co Ltd ,Kyoto University ,Manufacturing Organization ,Wuxi Biologics ,Wuxi Biologic ,Investigational New Drug ,Maxillofacial Surgery ,Sci Adv ,